<DOC>
	<DOCNO>NCT02856230</DOCNO>
	<brief_summary>Endovascular treatment knee disease well-established therapy improve outcome patient critical limb ischemia . Several large cohort study demonstrate safety efficacy percutaneous recanalization angioplasty distal vessel disease . A successful recanalization foot artery relate high ulcer heal reduction major amputation . Moreover absence revascularization patient critical limb ischemia independent risk factor mortality . Despite introduction new device dedicate knee vessel disease treatment , development guide conical balloon , long term patency outcome still poor . Restenosis observe two third patient within 3 month angioplasty tibial artery high target lesion revascularization . These re-interventions characterize high morbidity mortality due several comorbidities associate patient . These data confirm need obtain lasting result order improve long-term outcome patient . Recently , use drug-eluting balloon ( DEB ) reveal increase patency angioplasty femoral artery . On contrary , result BTK arteries angioplasty show controversial result . The purpose study evaluate safety efficacy Ranger™ SL paclitaxel coat balloon model drug elute balloon patient critical limb ischemia .</brief_summary>
	<brief_title>An Efficacy Safety Study Evaluate Ranger DEB BTK Angioplasty Patients With CLI ( RANGER-BTK )</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>General Inclusion Criteria : Age ≥18 year ≤85 year Patient sign approve consent form Patient document chronic Critical Limb Ischemia ( CLI ) target limb prior study procedure Rutherford Category 4 , 5 6 Menopausal contraception woman Negative serum βHCG woman childbearing age Angiographic Inclusion Criteria : Single multiple lesion ≥70 % diameter stenosis ( DS ) different lengths one main knee vessel Intraluminal recanalization target lesion successful traversal target lesion placement guidewire distal true lumen Reference vessel reference diameter comprise 2 4 mm General noninclusion criterion : Patient know hypersensitivity paclitaxel Patient unwilling unlikely comply FollowUp schedule Life expectancy &lt; 1 year ( investigator 's appreciation ) Planned major index limb amputation Pregnant breast feed woman Angiographic exclusion criterion : Significant ( ≥50 % DS ) inflow lesion occlusion ipsilateral iliac , superficial femoral popliteal artery treat successfully session Previously implant stent target lesion ( ) Aneurysm target vessel Acute thrombus target limb Failure cross target lesion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Critical limb ischemia</keyword>
	<keyword>bellow-the-knee angioplasty</keyword>
	<keyword>drug-eluting balloon</keyword>
</DOC>